Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 1380 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 3591 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 15054 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 27596 | Peak area | HGD & PDA | Yes |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 53979 | Peak area | HGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 57074 | Peak area | N/A | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 58624 | Peak area | HGD & PDA | yes |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 62221 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 102636 | Peak area | N/A | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 114509 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 136321 | Peak area | N/A | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+H)+ | 184429 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 4465 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 7018 | Peak area | HGD & PDA | Yes |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 15764 | Peak area | N/A | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 17991 | Peak area | HGD & PDA | yes |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 17992 | Peak area | HGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 27105 | Peak area | N/A | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 32972 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 35492 | Peak area | N/A | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 39927 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | 51588 | Peak area | LGD | No |
Reversed phase POSITIVE ION MODE | LYSINE (M+NA)+ | Peak area | LGD | No |